Literature DB >> 12578116

Impairment of beta-adrenergic signaling in healthy peripheral blood mononuclear cells exposed to serum from patients with septic shock: involvement of the inhibitory pathway of adenylyl cyclase stimulation.

Gilles Bernardin1, Roger Lema Kisoka, Christine Delporte, Patrick Robberecht, Jean-Louis Vincent.   

Abstract

The objective of this study was to determine whether the serum of patients with sepsis could alter the capability of healthy human peripheral blood mononuclear cells (PBMC) to synthesize cAMP in response to beta-adrenergic stimulation and to evaluate the involvement of the inhibitory pathway (Gi) of adenylyl cyclase in the sepsis-induced alteration of beta-adrenergic signaling. First, PBMC from a healthy donor were incubated for 24 h in serum-containing medium according to three culture conditions: serum alone, serum with pertussis toxin, and serum with propranolol. Second, PBMC were stimulated with 10(-5) M isoproterenol or 10(-6) M forskolin, and measurement of cyclic adenosine monophosphate (cAMP) intracellular accumulation was performed. Serum samples were obtained from three groups of subjects: 14 patients with severe sepsis, 21 patients with septic shock, and 10 healthy control subjects. Basal and forskolin-stimulated cAMP levels were similar in PBMC cultured in control or in septic serum. Isoproterenol-stimulated accumulation was reduced in PBMC preincubated in septic serum. The lowest cAMP levels were found after exposure to serum from patients with septic shock. The addition of pertussis toxin in the incubation medium constantly increased cAMP response to isoproterenol, but more significantly in PBMC exposed to septic serum. Incubation in the presence of propranolol had no significant effect. The serum of patients with sepsis contained soluble depressant substances that inhibited adenylyl cyclase activation by beta-adrenergic agonists. Septic shock serum exhibited the most potent inhibitory effect. Hyperactivation of the Gi pathway of adenylyl cyclase was mainly responsible for the altered transmembrane beta-adrenergic signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12578116     DOI: 10.1097/00024382-200302000-00003

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  4 in total

1.  Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.

Authors:  Andrea Morelli; Stefano De Castro; Jean-Louis Teboul; Mervyn Singer; Monica Rocco; Giorgio Conti; Leonardo De Luca; Emanuele Di Angelantonio; Alessandra Orecchioni; Natesa G Pandian; Paolo Pietropaoli
Journal:  Intensive Care Med       Date:  2005-04-06       Impact factor: 17.440

2.  Propranolol decreases cardiac work in a dose-dependent manner in severely burned children.

Authors:  Felicia N Williams; David N Herndon; Gabriela A Kulp; Marc G Jeschke
Journal:  Surgery       Date:  2011-02       Impact factor: 3.982

3.  Elevated Cyclic AMP Inhibits Mycobacterium tuberculosis-Stimulated T-cell IFN-γ Secretion Through Type I Protein Kinase A.

Authors:  Yoon-Tae Chung; Virginia Pasquinelli; Javier O Jurado; Xisheng Wang; Na Yi; Peter F Barnes; Veronica E Garcia; Buka Samten
Journal:  J Infect Dis       Date:  2018-05-05       Impact factor: 5.226

4.  Effects of forskolin on Kupffer cell production of interleukin-10 and tumor necrosis factor alpha differ from those of endogenous adenylyl cyclase activators: possible role for adenylyl cyclase 9.

Authors:  Maria K Dahle; Anders E Myhre; Ansgar O Aasen; Jacob E Wang
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.